Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence.

Berger M, Krebs P, Crozat K, Li X, Croker BA, Siggs OM, Popkin D, Du X, Lawson BR, Theofilopoulos AN, Xia Y, Khovananth K, Moresco EM, Satoh T, Takeuchi O, Akira S, Beutler B.

Nat Immunol. 2010 Apr;11(4):335-43. doi: 10.1038/ni.1847. Epub 2010 Feb 28.

2.

Effect of Schlafen 2 on natural killer and T cell development from common T/natural killer progenitors.

Ahmadi S, Veinotte LL.

Pak J Biol Sci. 2011 Nov 15;14(22):1002-10.

PMID:
22514877
3.

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.

Chun HJ, Zheng L, Ahmad M, Wang J, Speirs CK, Siegel RM, Dale JK, Puck J, Davis J, Hall CG, Skoda-Smith S, Atkinson TP, Straus SE, Lenardo MJ.

Nature. 2002 Sep 26;419(6905):395-9.

PMID:
12353035
4.

Loss of T-cell quiescence by targeting Slfn2 prevents the development and progression of T-ALL.

Goldshtein A, Zerbib SM, Omar I, Cohen-Daniel L, Popkin D, Berger M.

Oncotarget. 2016 Jul 26;7(30):46835-46847. doi: 10.18632/oncotarget.9390.

5.

Reduced thymic output, cell cycle abnormalities, and increased apoptosis of T lymphocytes in patients with cartilage-hair hypoplasia.

de la Fuente MA, Recher M, Rider NL, Strauss KA, Morton DH, Adair M, Bonilla FA, Ochs HD, Gelfand EW, Pessach IM, Walter JE, King A, Giliani S, Pai SY, Notarangelo LD.

J Allergy Clin Immunol. 2011 Jul;128(1):139-46. doi: 10.1016/j.jaci.2011.03.042. Epub 2011 May 13.

6.

Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3'-long terminal repeat transgene.

Lindemann D, Wilhelm R, Renard P, Althage A, Zinkernagel R, Mous J.

J Exp Med. 1994 Mar 1;179(3):797-807.

7.

Schlafen2 mutation unravels a role for chronic ER stress in the loss of T cell quiescence.

Omar I, Lapenna A, Cohen-Daniel L, Tirosh B, Berger M.

Oncotarget. 2016 Jun 28;7(26):39396-39407. doi: 10.18632/oncotarget.9818.

8.

Quieting T cells with Slfn2.

Horton MR, Powell JD.

Nat Immunol. 2010 Apr;11(4):281-2. doi: 10.1038/ni0410-281. Review. No abstract available.

9.

Primary severe immunodeficiency due to impaired signal transduction in T cells.

Schlesier M, Niemeyer C, Duffner U, Henschen M, Tanzi-Fetta R, Wolff-Vorbeck G, Dräger R, Brandis M, Peter HH.

Immunodeficiency. 1993;4(1-4):133-6. No abstract available.

PMID:
8167687
10.

Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions.

Tesselaar K, Arens R, van Schijndel GM, Baars PA, van der Valk MA, Borst J, van Oers MH, van Lier RA.

Nat Immunol. 2003 Jan;4(1):49-54. Epub 2002 Dec 9. Erratum in: Nat Immunol. 2003 Mar;4(3):295.

PMID:
12469117
11.

Immunodeficiency and immune dysregulation associated with proximal defects of T cell receptor signaling.

Notarangelo LD.

Curr Opin Immunol. 2014 Dec;31:97-101. doi: 10.1016/j.coi.2014.10.003. Epub 2014 Oct 25. Review.

12.

Primary T lymphocyte immunodeficiency associated with a selective impairment of CD2, CD3, CD43 (but not CD28)-mediated signal transduction.

Rodríguez-Gallego C, Arnaiz-Villena A, Corell A, Manzanares J, Timón M, Pacheco A, Regueiro JR.

Clin Exp Immunol. 1994 Sep;97(3):386-91.

13.

Severe combined immunodeficiency due to a specific defect in the production of interleukin-2.

Weinberg K, Parkman R.

N Engl J Med. 1990 Jun 14;322(24):1718-23. No abstract available.

14.

Clinical, immunologic and genetic profiles of DOCK8-deficient patients in Kuwait.

Al-Herz W, Ragupathy R, Massaad MJ, Al-Attiyah R, Nanda A, Engelhardt KR, Grimbacher B, Notarangelo L, Chatila T, Geha RS.

Clin Immunol. 2012 Jun;143(3):266-72. doi: 10.1016/j.clim.2012.03.002. Epub 2012 Mar 30.

15.

Mutation in the TCRα subunit constant gene (TRAC) leads to a human immunodeficiency disorder characterized by a lack of TCRαβ+ T cells.

Morgan NV, Goddard S, Cardno TS, McDonald D, Rahman F, Barge D, Ciupek A, Straatman-Iwanowska A, Pasha S, Guckian M, Anderson G, Huissoon A, Cant A, Tate WP, Hambleton S, Maher ER.

J Clin Invest. 2011 Feb;121(2):695-702. doi: 10.1172/JCI41931. Epub 2011 Jan 4.

16.

Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes.

Apolloni E, Bronte V, Mazzoni A, Serafini P, Cabrelle A, Segal DM, Young HA, Zanovello P.

J Immunol. 2000 Dec 15;165(12):6723-30.

17.

Regeneration and tolerance factor is expressed during T-lymphocyte activation and plays a role in apoptosis.

Boomer JS, Derks RA, Lee GW, DuChateau BK, Gilman-Sachs A, Beaman KD.

Hum Immunol. 2001 Jun;62(6):577-88.

PMID:
11390032
18.

Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase.

Suzuki H, Terauchi Y, Fujiwara M, Aizawa S, Yazaki Y, Kadowaki T, Koyasu S.

Science. 1999 Jan 15;283(5400):390-2.

19.

Interpretation of lymphocyte proliferation tests.

Bonilla FA.

Ann Allergy Asthma Immunol. 2008 Jul;101(1):101-4. doi: 10.1016/S1081-1206(10)60842-3. No abstract available.

PMID:
18681092
20.

[T cell receptor, immunoglobulin genes and immunodeficiency].

Kurosawa Y.

Tanpakushitsu Kakusan Koso. 1991 Aug;36(10):1741-6. Japanese. No abstract available.

PMID:
1947183

Supplemental Content

Support Center